éå»1ã¶æéã«Ovid Therapeutics Incã«å¯ŸããŠè©äŸ¡ãåºããã¢ããªã¹ã13åã«åºã¥ãããŒã¿ã
仿ãOVIDã¯6ä»¶ã®ãè²·ããã0ä»¶ã®ãäžç«ïŒããŒã«ãïŒãã0ä»¶ã®ã売ããè©äŸ¡ãç²åŸããŸãããçŽè¿1ã¶æã«ãããOVIDã®ã¢ããªã¹ãå¹³åç®æšæ ªäŸ¡ã¯6.400ã§ãã
ã¢ããªã¹ãäºæ³ã«ãããšãFY2026Q3ã«çºè¡šãããEPS -0.102ã«ç¶ããOVIDã®FY2026Q4ã®EPSã¯-0.099ã«éããèŠéãã§ããçºè¡šãããå®çžŸå€ãšäºæ³ãæ¯èŒããŠãåçæ§ã®æšç§»ã確èªããŸãããã
åžå Žäºæ³ã¯ USD -0.10 ã§ããããOvid Therapeutics IncOVID ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD -0.08 ã§ãããæ¬¡ã®ååæã® EPS 㯠USD -0.10 ãšäºæ³ãããŸãã